Hepion Pharma HEPA

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Of course, approval news is the ultimate "as huge as it gets" news. But at this stage...
Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
Internet Stock Review

Is The Market Overvalued? Barron’s Round Table January 2000.

Interesting viewpoints ahead of the market drifting from near 12,000 to 7,000. Equivalent to Dow dropping to near 20,000 today.
dexamethasone, Hepion

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...

Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Hapbee

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Hapbee Announces Additions to Advisory Board December 17, 2020 New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
HAPBEE

Hapbee (HAPB): The Netflix of Feelings

After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
BioSig, Biotech Stock Review

BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence Westport,...
Dr. Marc Hellerstein

Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.

Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...
Cyclophilin, Biotech Stock Review

Adding Hepion Pharma (HEPA) $1.73 to Watch List.

Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here? Oh my…and Oh boy....
Internet Stock Review

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....

Latest article

Wall Street Pounces on Hydroponics.

Indoor Growing & Hydroponics Outperform Both the Market and Marijuana Sector. Investor attention is...

Another Look at the Snowflake (SNOW) Mega IPO.

We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...
Citius

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.

Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today. We're beginning to believe (and...